These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 38005286)
21. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles. Wu J; Zhang J; Deng C; Meng F; Zhong Z Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935 [TBL] [Abstract][Full Text] [Related]
25. Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer. Choi KY; Jeon EJ; Yoon HY; Lee BS; Na JH; Min KH; Kim SY; Myung SJ; Lee S; Chen X; Kwon IC; Choi K; Jeong SY; Kim K; Park JH Biomaterials; 2012 Sep; 33(26):6186-93. PubMed ID: 22687759 [TBL] [Abstract][Full Text] [Related]
26. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy. Gao Z; Li Z; Yan J; Wang P Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710 [TBL] [Abstract][Full Text] [Related]
27. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery. Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238 [TBL] [Abstract][Full Text] [Related]
28. Targeting pentamidine towards CD44-overexpressing cells using hyaluronated lipid-polymer hybrid nanoparticles. Andreana I; Chiapasco M; Bincoletto V; Digiovanni S; Manzoli M; Ricci C; Del Favero E; Riganti C; Arpicco S; Stella B Drug Deliv Transl Res; 2024 Aug; 14(8):2100-2111. PubMed ID: 38709442 [TBL] [Abstract][Full Text] [Related]
29. Apigenin-loaded galactose tailored PLGA nanoparticles: A possible strategy for liver targeting to treat hepatocellular carcinoma. Ganguly S; Dewanjee S; Sen R; Chattopadhyay D; Ganguly S; Gaonkar R; Debnath MC Colloids Surf B Biointerfaces; 2021 Aug; 204():111778. PubMed ID: 33915380 [TBL] [Abstract][Full Text] [Related]
30. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells. Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421 [TBL] [Abstract][Full Text] [Related]
31. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176 [TBL] [Abstract][Full Text] [Related]
32. Shifting the absorption to the near-infrared region and inducing a strong photothermal effect by encapsulating zinc(II) phthalocyanine in poly(lactic-co-glycolic acid)-hyaluronic acid nanoparticles. Gao D; Wong RCH; Wang Y; Guo X; Yang Z; Lo PC Acta Biomater; 2020 Oct; 116():329-343. PubMed ID: 32890751 [TBL] [Abstract][Full Text] [Related]
33. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting. Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660 [TBL] [Abstract][Full Text] [Related]
34. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560 [TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995 [TBL] [Abstract][Full Text] [Related]
36. Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages. Hlaing SP; Cao J; Lee J; Kim J; Saparbayeva A; Kwak D; Kim H; Hwang S; Yun H; Moon HR; Jung Y; Yoo JW Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297553 [TBL] [Abstract][Full Text] [Related]
37. Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells. Cerqueira BBS; Lasham A; Shelling AN; Al-Kassas R Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():593-600. PubMed ID: 28482569 [TBL] [Abstract][Full Text] [Related]
38. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy. Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837 [TBL] [Abstract][Full Text] [Related]
39. Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy. Edelman R; Assaraf YG; Levitzky I; Shahar T; Livney YD Oncotarget; 2017 Apr; 8(15):24337-24353. PubMed ID: 28212584 [TBL] [Abstract][Full Text] [Related]
40. Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer. Yang Z; Luo H; Cao Z; Chen Y; Gao J; Li Y; Jiang Q; Xu R; Liu J Nanoscale; 2016 Jun; 8(22):11543-58. PubMed ID: 27203688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]